Literature DB >> 7614966

Serotypes and resistance patterns of Streptococcus pneumoniae causing systemic disease in northern Norway.

T Magnus1, B M Andersen.   

Abstract

During the period 1985-1990, Streptococcus pneumoniae was isolated form 97 patients with systemic pneumococcal disease in Northern Norway. Systemic disease occurred most frequently in the age groups 0-4 years and > 60 years. An increasing incidence was observed, especially among children less than five years old. Serotypes covered by the 23-valent pneumococcal polysaccharide vaccine were found in 86 of 97 (88.7%) isolates. The vaccine did not cover 16.7% of the systemic isolates from children less than five years old. Reduced sensitivity to penicillin was found in one isolate (1.0%) which was resistant to ampicillin, doxycycline and chloramphenicol. The E-test and the Rosco agar diffusion test differed in sensitivity to penicillin, chloramphenicol, ciprofloxacin and erythromycin. Three serotype 12F strains showed unusual cross-resistance to chloramphenicol and erythromycin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614966     DOI: 10.1007/BF02310362

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  26 in total

1.  Increasing penicillin resistance in pneumococci in Iceland.

Authors:  K G Kristinsson; M A Hjálmarsdóttir; O Steingrímsson
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

2.  Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria.

Authors:  C N Baker; S A Stocker; D H Culver; C Thornsberry
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

3.  New 23-valent pneumococcal vaccine in relation to pneumococcal serotypes in systemic and non-systemic disease.

Authors:  L E Smart; A J Dougall; R W Girdwood
Journal:  J Infect       Date:  1987-05       Impact factor: 6.072

4.  Alterations in penicillin-binding proteins of clinical and laboratory isolates of pathogenic Streptococcus pneumoniae with low levels of penicillin resistance.

Authors:  S Handwerger; A Tomasz
Journal:  J Infect Dis       Date:  1986-01       Impact factor: 5.226

5.  Multiply resistant pneumococci in The Netherlands.

Authors:  Y Holloway; J Schiphuis; M Kooistra-Smid; J A Snijder; P C Appelbaum; S K Spangler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-04       Impact factor: 3.267

6.  Distribution of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated in Brazil from 1988 to 1992.

Authors:  J F Sessegolo; A S Levin; C E Levy; M Asensi; R R Facklam; L M Teixeira
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

7.  Host defense against Streptococcus pneumoniae: the role of the spleen.

Authors:  D W Wara
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

8.  Pneumococcal bacteremia in adults over a 10-year period at University Hospital, Leiden.

Authors:  G A Bruyn; J W van der Meer; J Hermans; W Knoppert
Journal:  Rev Infect Dis       Date:  1988 Mar-Apr

9.  Factors influencing the risk of early and late serious infection in adults after splenectomy for trauma.

Authors:  M A Malangoni; L D Dillon; T W Klamer; R E Condon
Journal:  Surgery       Date:  1984-10       Impact factor: 3.982

10.  Clinical and epidemiologic studies of pneumococcal infection in children.

Authors:  B M Gray; H C Dillon
Journal:  Pediatr Infect Dis       Date:  1986 Mar-Apr
View more
  5 in total

Review 1.  New pneumococcal vaccines for children.

Authors:  S Choo; A Finn
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

Review 2.  Antibiotic resistant Streptococcus pneumoniae.

Authors:  E J Minton; J T Macfarlane
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

3.  Burden of paediatric invasive pneumococcal disease in Europe, 2005.

Authors:  E D G McIntosh; B Fritzell; M A Fletcher
Journal:  Epidemiol Infect       Date:  2006-09-07       Impact factor: 2.451

Review 4.  Advances in pneumococcal vaccines: advantages for infants and children.

Authors:  Jolanta Bernatoniene; Adam Finn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94.

Authors:  S V Nielsen; J Henrichsen
Journal:  Epidemiol Infect       Date:  1996-12       Impact factor: 2.451

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.